Instruction for use: Talliton

Trade name of the drug – Talliton

Dosage Form: tablets

Composition (per tablet): 1 tablet contains carvedilol 6.25, 12.5 or 25 mg; in blister 14 pcs.; in the paper cartons 1 or 2 blisters or in dark glass bottles of 20 or 30 pcs .; In the paper cartons 1 bottle.

Excipients: lactose monohydrate; sucrose; Colloidal anhydrous silica; povidone K-25; crospovidone; magnesium stearate; dyes - ariavit quinoline yellow (tablets of 6.25 mg), yellow ariavit "sunset" (12.5 mg tablet)

Pharmacotherapeutic group: Alpha- and beta-blockers

ATC C07AG02 Carvedilol

The nosological classification (ICD-10)

I10 Essential (primary) hypertension: hypertension; Arterial hypertension; Arterial hypertension crisis course; Essential Hypertension; Essential hypertension; Essential hypertension; Essential hypertension; Essential hypertension; Primary hypertension; Arterial hypertension, complications of diabetes; The sudden increase in blood pressure; Hypertensive disorders of blood circulation; hypertensive condition; hypertensive crises; arterial Hypertension; malignant Hypertension; Hypertonic disease; hypertensive crises; accelerated hypertension; malignant hypertension; The aggravation of hypertensive disease; Transient hypertension; Isolated systolic hypertension

I15 Secondary hypertension: Arterial hypertension, complications of diabetes; hypertension; The sudden increase in blood pressure; Hypertensive disorders of blood circulation; hypertensive condition; hypertensive crises; hypertension; arterial Hypertension; malignant Hypertension; hypertensive crises; accelerated hypertension; malignant hypertension; The aggravation of hypertensive disease; Transient hypertension; hypertension; Arterial hypertension; Arterial hypertension crisis course; renovascular hypertension; Hypertension symptomatic; Renal hypertension; Renovascular hypertension; renovascular hypertension; Symptomatic hypertension

I20 Angina [angina]: Heberden disease; Angina pectoris; The attack of angina pectoris; recurrent angina; Spontaneous angina; Stable angina pectoris; Angina rest; Angina progressing; Angina mixed; Angina spontaneous; stable angina; Chronic stable angina; Angina Syndrome X

I25.9 Chronic ischemic heart disease, unspecified: CHD; Insufficiency of coronary circulation; Coronary atherosclerosis in patients with coronary artery disease

I50.0 Congestive heart failure: anasarca heart; Decompensated congestive heart failure; Congestive heart failure; Congestive heart failure with high afterload; Congestive chronic heart failure; Cardiomyopathy with severe chronic heart failure; Compensated chronic heart failure; Swelling with circulatory failure; Edema of cardiac origin; Swelling of the heart; Edematous syndrome in diseases of the heart; Edematous syndrome in congestive heart failure; Edematous syndrome in heart failure; Edematous syndrome in heart failure or liver cirrhosis; right ventricular failure; Congestive Heart Failure; Heart failure stagnant; Heart failure with low cardiac output; Heart failure is a chronic; Cardiac edema; Chronic decompensated heart failure; Chronic Congestive Heart Failure; Chronic heart failure; Change of liver function in heart failure

Pharmacological Properties of Carvedilol

Pharmachologic effect - Mode of action - antianginal, hypotensive.

Talliton Dosage and Administration

Inside, the tablets should be swallowed whole and drink plenty of water.

In essential hypertension:.. Recommended initial dose - 12,5 mg Tallitona® 1 times a day for 2 days (Table 1, 12.5 mg in the morning or 1 Table 6.25 mg 2 times a day - one in the morning and the other - in the evening). The recommended maintenance dose - Tallitona® 25 mg (1 tablet of 25 mg in the morning and 1 tablet of 12.5 mg 2 times a day -.. 1 in the morning and the other - in the evening). In the case of unsatisfactory results, but not earlier than 14 days of treatment, the dose can be increased to a maximum - 50 mg per day (1 tab 25 mg 2 times a day -. Morning and evening). The maximum single dose - 25 mg daily dose should not exceed 50 mg.

Stable angina pectoris: The recommended initial dose - 12.5 mg 2 times a day (morning and evening) during the first 2 days. The recommended maintenance dose - 25 mg 2 times a day (morning and evening). In the case of unsatisfactory results, but not earlier than 14 days of treatment, the dose can be increased to a maximum - 50 mg 2 times a day (2 tablets of 25 mg in the morning and 2 tablets in the evening..).

Chronic heart failure: the dose should be selected individually, while increasing the dose to carry out a thorough monitoring. It should be to observe the condition of the patient within 2-3 hours after the first dose or increased after the first dose. Additional Talliton® application requires a stable clinical condition. The dose and the appointment of such drugs as digoxin, diuretics and ACE inhibitors should be fixed prior to the appointment Talliton®. Patients need to take tablets during the meal (to reduce the risk of orthostatic hypotension).

The recommended starting dose - 3.125 mg 2 times a day for 14 days (Table 1.2 by 6.25 mg in the morning and evening.). If the treatment is well tolerated by the patient, and in this there is a need, then the dose can be increased to 6.25 mg 2 times a day (see Table 1 at 6.25 mg in the morning and 1 -. The evening). Perhaps a subsequent increase in the dose of 12.5 mg 2 times a day (1 tab. 12.5 mg in the morning and in the evening), and then to 25 mg 2 times a day (1 tab. 25 mg in the morning and evening). Patients administered the maximum tolerated dose. The maximum recommended dose: 25 mg 2 times a day (1 tab 25 mg in the morning and 1 - in the evening.) - For patients weighing up to 85 kg and 50 mg twice a day (2 tablets of 25 mg in the morning and 2. - evening) - for patients weighing more than 85 kg. Patients with heart failure to prevent orthostatic hypotension it is recommended to take the drug during meals.

At the beginning of the treatment and to increase each dose condition of patients should be monitored, because possibly worsening heart failure. May develop fluid retention, and due to the vasodilator effect - hypotension and lethargy. When fluid retention should increase the dose of diuretics, in addition, may require temporary dose reduction Talliton®. In some cases, treatment should be temporarily suspend Talliton®.

Storage conditions of Talliton

In a dry, dark place at a temperature 15-25° C.

Keep out of the reach of children.

Shelf life

5 years.

Do not use beyond the expiration date printed on the package.

Conditions of supply of pharmacies

On prescription.